BR0213538A - Doença bacteriana de aves domésticas - Google Patents

Doença bacteriana de aves domésticas

Info

Publication number
BR0213538A
BR0213538A BR0213538-8A BR0213538A BR0213538A BR 0213538 A BR0213538 A BR 0213538A BR 0213538 A BR0213538 A BR 0213538A BR 0213538 A BR0213538 A BR 0213538A
Authority
BR
Brazil
Prior art keywords
disease
mannheimia haemolytica
bacterial disease
pasteurella trehalosi
poultry bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BR0213538-8A
Other languages
English (en)
Inventor
Maria Elena Vazquez
Raul Campogarrido
Carlos Gonzales-Hernandez
Vaithianathan Sivanandan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica de C V SA
Original Assignee
Boehringer Ingelheim Vetmedica de C V SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica de C V SA filed Critical Boehringer Ingelheim Vetmedica de C V SA
Publication of BR0213538A publication Critical patent/BR0213538A/pt
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)

Abstract

"DOENçA BACTERIANA DE AVES DOMéSTICAS". A presente invenção pertence ao campo da saúde animal e, em particular, ao agente causador de uma nova doença bacteriana de aves domésticas, Pasteurella trehalosi e/ou Mannheimia haemolytica. A invenção proporciona as ditas bactérias Pasteurella trehalosi e/ou Mannheimia haemolytica, uma vacina compreendendo as ditas Pasteurella trehalosi e/ou Mannheimia haemolytica inativadas e um método de imunização para prevenir a doença em galinhas.
BR0213538-8A 2001-10-26 2002-10-24 Doença bacteriana de aves domésticas Pending BR0213538A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152307A DE10152307A1 (de) 2001-10-26 2001-10-26 Neue bakterielle Geflügelkrankheit
PCT/EP2002/011899 WO2003037367A2 (en) 2001-10-26 2002-10-24 New bacterium causing poultry disease and vaccine derived thereof

Publications (1)

Publication Number Publication Date
BR0213538A true BR0213538A (pt) 2004-10-19

Family

ID=7703460

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213538-8A Pending BR0213538A (pt) 2001-10-26 2002-10-24 Doença bacteriana de aves domésticas

Country Status (32)

Country Link
US (3) US7794735B2 (pt)
EP (2) EP1942181A1 (pt)
JP (2) JP4447319B2 (pt)
KR (2) KR101024887B1 (pt)
CN (1) CN100471945C (pt)
AR (3) AR037020A1 (pt)
AT (1) ATE391767T1 (pt)
AU (1) AU2002363173B2 (pt)
BR (1) BR0213538A (pt)
CA (1) CA2462652A1 (pt)
CO (1) CO5580796A2 (pt)
CY (1) CY1108178T1 (pt)
DE (2) DE10152307A1 (pt)
DK (1) DK1442114T3 (pt)
EC (1) ECSP045083A (pt)
ES (1) ES2304466T3 (pt)
HK (1) HK1073862A1 (pt)
HR (1) HRP20040366B1 (pt)
HU (1) HU228692B1 (pt)
IL (1) IL161223A0 (pt)
MA (1) MA26293A1 (pt)
MX (1) MXPA04003941A (pt)
MY (1) MY138203A (pt)
NO (1) NO333635B1 (pt)
NZ (1) NZ532805A (pt)
PL (1) PL206589B1 (pt)
PT (1) PT1442114E (pt)
RU (4) RU2334792C2 (pt)
SI (1) SI1442114T1 (pt)
UA (2) UA96948C2 (pt)
WO (1) WO2003037367A2 (pt)
ZA (1) ZA200402499B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
US20120258515A1 (en) * 2009-10-09 2012-10-11 Københavns Universitet Cytolytic RTX-Toxin From Gallibacterium Anatis
CN102380092A (zh) * 2011-11-22 2012-03-21 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗
CN102406936A (zh) * 2011-11-22 2012-04-11 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗佐剂
WO2014147001A1 (en) 2013-03-18 2014-09-25 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
RU2563885C1 (ru) * 2014-06-03 2015-09-27 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ определения антител к бактериальным антигенам
CN104491856A (zh) * 2014-12-07 2015-04-08 青岛易邦生物工程有限公司 一种禽肺病毒病灭活疫苗的生产方法
CN108728558A (zh) * 2018-05-31 2018-11-02 广西壮族自治区兽医研究所 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用
CN111621450B (zh) * 2020-07-10 2022-07-05 青岛易邦生物工程有限公司 一种鸭源鸡杆菌及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
ZA937652B (en) 1992-10-14 1994-05-04 Akzo Nv New bacterium causing poultry disease and vaccine derived thereof
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
RU94023126A (ru) * 1994-06-16 1997-04-10 Всероссийский научно-исследовательский институт экспериментальной ветеринарии им.Я.Р.Коваленко Вакцина против пастереллеза свиней
RU2103355C1 (ru) * 1995-11-23 1998-01-27 Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии Способ получения аттенуированных иммуногенных штаммов pasteurella multocida
FR2760640B1 (fr) * 1997-03-17 1999-05-28 Vetoquinol Sa Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica
US7304151B2 (en) * 1999-12-17 2007-12-04 University Of Guelph Modified leukotoxin gene and protein
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
US7521060B2 (en) * 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease

Also Published As

Publication number Publication date
AR067732A2 (es) 2009-10-21
HRP20040366B1 (en) 2012-05-31
HU228692B1 (en) 2013-05-28
JP2005511032A (ja) 2005-04-28
MXPA04003941A (es) 2004-11-29
MY138203A (en) 2009-05-29
NZ532805A (en) 2008-04-30
DE10152307A1 (de) 2003-05-08
RU2481393C2 (ru) 2013-05-10
MA26293A1 (fr) 2004-09-01
RU2007148219A (ru) 2009-07-10
RU2430967C2 (ru) 2011-10-10
RU2334792C2 (ru) 2008-09-27
PT1442114E (pt) 2008-05-20
RU2004116134A (ru) 2005-05-10
ES2304466T3 (es) 2008-10-16
AU2002363173B2 (en) 2007-09-20
RU2007129099A (ru) 2009-02-10
US7794735B2 (en) 2010-09-14
WO2003037367A3 (en) 2003-10-09
KR100954175B1 (ko) 2010-04-20
EP1442114A2 (en) 2004-08-04
US20100104594A1 (en) 2010-04-29
PL206589B1 (pl) 2010-08-31
DE60226057T2 (de) 2009-05-14
JP4447319B2 (ja) 2010-04-07
IL161223A0 (en) 2004-09-27
DK1442114T3 (da) 2008-06-09
CN1575334A (zh) 2005-02-02
CY1108178T1 (el) 2014-02-12
JP2010051324A (ja) 2010-03-11
US20090181055A1 (en) 2009-07-16
HK1073862A1 (en) 2005-10-21
JP5087604B2 (ja) 2012-12-05
EP1442114B1 (en) 2008-04-09
CN100471945C (zh) 2009-03-25
CO5580796A2 (es) 2005-11-30
DE60226057D1 (de) 2008-05-21
HRP20040366A2 (en) 2005-04-30
CA2462652A1 (en) 2003-05-08
KR20050039688A (ko) 2005-04-29
AR073482A2 (es) 2010-11-10
NO20041675L (no) 2004-04-23
AR037020A1 (es) 2004-10-20
RU2456343C2 (ru) 2012-07-20
UA89607C2 (ru) 2010-02-25
EP1942181A1 (en) 2008-07-09
RU2008136404A (ru) 2010-03-20
KR101024887B1 (ko) 2011-03-31
ZA200402499B (en) 2005-06-08
PL369963A1 (en) 2005-05-02
SI1442114T1 (sl) 2008-08-31
ECSP045083A (es) 2004-08-27
UA96948C2 (ru) 2011-12-26
WO2003037367A2 (en) 2003-05-08
HUP0402098A2 (hu) 2005-02-28
NO333635B1 (no) 2013-07-29
KR20090083941A (ko) 2009-08-04
ATE391767T1 (de) 2008-04-15
US7964197B2 (en) 2011-06-21
US20110212132A1 (en) 2011-09-01
HUP0402098A3 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
UA81676C2 (ru) Композиция для лечения инфекций у крупного рогатого скота и свиней
DE69636228D1 (de) Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
DE60316772D1 (de) Von menschen oder tieren verwenbare diätetische und/oder pharmazeutische zubereitungen, auf basis von probiotischen mikroorganismen
DE69820265D1 (de) Für den vogelembryo geeignete multivalente impfstoffe
BR0013010B1 (pt) Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
HUP0301634A2 (hu) Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
BR0006291A (pt) Bactéria do gênero salmonella, vacina para aproteção de animais contra a salmonelose, uso deuma bactéria, e, processo para a preparação deuma vacina
BR0012654A (pt) Método para amaciamento de carne, produto de carne amaciada, e, composição de amaciamento de carne
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
KR930007365A (ko) 조류사료첨가용 장내 유해세균 억제제
AR009650A1 (es) Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna.
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása
MXPA05012219A (es) Vacuna aviar combinada contra e. coli y salmonella.
GB2377638B (en) Treatment of infection in animals
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
Verma et al. Erysipeloid: occupational disease
BR9712633A (pt) Método para o tratamento de infecção por streptococcus pneumoniae
DK1660121T3 (da) Levende svækket bakteriel vaccine
Coates The anthrax alarm bells doctor's diary
BG104235A (en) Application of 8a-azalides as veterinary antimicrobial forms
TH78298B (th) โรคสัตว์ปีกชนิดใหม่ที่เกิดจากแบคทีเรีย
RU95117747A (ru) Аттенуированный иммуногенный штамм бактерий pasteurella multocida sm1, используемый для приготовления препарата живой вакцины против пастереллеза кур и индеек

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S)8O, 13), 24, 25, 32 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.